On Nov. 8, the FDA approved Eli Lilly’s Zepbound (tirzepatide), a weekly injection for chronic weight management.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves new weight loss drug
On Nov. 8, the FDA approved Eli Lilly’s Zepbound (tirzepatide), a weekly injection for chronic weight management.
Read the full post on Becker's Hospital Review - Healthcare News